232 related articles for article (PubMed ID: 7522635)
1. Expression of recombinant transmembrane CD59 in paroxysmal nocturnal hemoglobinuria B cells confers resistance to human complement.
Rother RP; Rollins SA; Mennone J; Chodera A; Fidel SA; Bessler M; Hillmen P; Squinto SP
Blood; 1994 Oct; 84(8):2604-11. PubMed ID: 7522635
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which the surface expression of the glycosyl-phosphatidylinositol-anchored complement regulatory proteins decay-accelerating factor (CD55) and CD59 is lost in human leukaemia cell lines.
Hatanaka M; Seya T; Matsumoto M; Hara T; Nonaka M; Inoue N; Takeda J; Shimizu A
Biochem J; 1996 Mar; 314 ( Pt 3)(Pt 3):969-76. PubMed ID: 8615796
[TBL] [Abstract][Full Text] [Related]
3. Deficient surface expression of glycosylphosphatidylinositol-anchored proteins in B cell lines established from patients with paroxysmal nocturnal hemoglobinuria.
Ueda E; Nishimura J; Kitani T; Nasu K; Kageyama T; Kim YU; Takeda J; Kinoshita T
Int Immunol; 1992 Nov; 4(11):1263-71. PubMed ID: 1282030
[TBL] [Abstract][Full Text] [Related]
4. The PIG-anchoring defect in NK lymphocytes of PNH patients.
Schubert J; Uciechowski P; Delany P; Tischler HJ; Kolanus W; Schmidt RE
Blood; 1990 Sep; 76(6):1181-7. PubMed ID: 1698101
[TBL] [Abstract][Full Text] [Related]
5. Preferential expression of human Fc gamma RIIIPMN (CD16) in paroxysmal nocturnal hemoglobinuria. Discordant expression of glycosyl phosphatidylinositol-linked proteins.
Edberg JC; Salmon JE; Whitlow M; Kimberly RP
J Clin Invest; 1991 Jan; 87(1):58-67. PubMed ID: 1702101
[TBL] [Abstract][Full Text] [Related]
6. Efficient retrovirus-mediated PIG-A gene transfer and stable restoration of GPI-anchored protein expression in cells with the PNH phenotype.
Nishimura Ji ; Phillips KL; Ware RE; Hall S; Wilson L; Gentry TL; Howard TA; Murakami Y; Shibano M; Machii T; Gilboa E; Kanakura Y; Takeda J; Kinoshita T; Rosse WF; Smith CA
Blood; 2001 May; 97(10):3004-10. PubMed ID: 11342424
[TBL] [Abstract][Full Text] [Related]
7. Impaired hematopoiesis in paroxysmal nocturnal hemoglobinuria/aplastic anemia is not associated with a selective proliferative defect in the glycosylphosphatidylinositol-anchored protein-deficient clone.
Maciejewski JP; Sloand EM; Sato T; Anderson S; Young NS
Blood; 1997 Feb; 89(4):1173-81. PubMed ID: 9028939
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and diagnosis of paroxysmal nocturnal hemoglobinuria: correlates with the deficiency of GPI-anchored membrane proteins].
Ninomiya H
Rinsho Ketsueki; 1994 Apr; 35(4):352-7. PubMed ID: 7518013
[TBL] [Abstract][Full Text] [Related]
9. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
Shichishima T
Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
[TBL] [Abstract][Full Text] [Related]
10. Correction of the PNH defect by GPI-anchored protein transfer.
Sloand EM; Maciejewski JP; Dunn D; Moss J; Brewer B; Kirby M; Young NS
Blood; 1998 Dec; 92(11):4439-45. PubMed ID: 9834251
[TBL] [Abstract][Full Text] [Related]
11. Robust in vitro replication of Plasmodium falciparum in glycosyl-phosphatidylinositol-anchored membrane glycoprotein-deficient red blood cells.
Pattanapanyasat K; Walsh DS; Yongvanitchit K; Piyawatthanasakul N; Wanachiwanawin W; Webster HK
Am J Trop Med Hyg; 2003 Oct; 69(4):360-5. PubMed ID: 14640493
[TBL] [Abstract][Full Text] [Related]
12. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
Mevorach D
Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
[TBL] [Abstract][Full Text] [Related]
13. Discordant and heterogeneous expression of GPI-anchored membrane proteins on leukemic cells in a patient with paroxysmal nocturnal hemoglobinuria.
Shichishima T; Terasawa T; Hashimoto C; Ohto H; Takahashi M; Shibata A; Maruyama Y
Blood; 1993 Apr; 81(7):1855-62. PubMed ID: 7681703
[TBL] [Abstract][Full Text] [Related]
14. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
Shichishima T; Noji H
Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
[TBL] [Abstract][Full Text] [Related]
15. Glycosyl phosphatidylinositol-linked blood group antigens and paroxysmal nocturnal hemoglobinuria.
Telen MJ
Transfus Clin Biol; 1995; 2(4):277-90. PubMed ID: 8542026
[TBL] [Abstract][Full Text] [Related]
16. Production and characterization of lymphoblastoid cell lines with the paroxysmal nocturnal hemoglobinuria phenotype.
Hillmen P; Bessler M; Crawford DH; Luzzatto L
Blood; 1993 Jan; 81(1):193-9. PubMed ID: 7678064
[TBL] [Abstract][Full Text] [Related]
17. [Paroxysmal nocturnal hemoglobinuria (PNH) deficiency of major complement-regulatory membrane proteins on erythrocytes].
Ninomiya H; Kobayashi T; Abe T
Rinsho Ketsueki; 1991 Jun; 32(6):612-7. PubMed ID: 1716325
[TBL] [Abstract][Full Text] [Related]
18. Expression of the glycosylphosphatidylinositol-linked complement-inhibiting protein CD59 antigen in insect cells using a baculovirus vector.
Davies A; Morgan BP
Biochem J; 1993 Nov; 295 ( Pt 3)(Pt 3):889-96. PubMed ID: 7694573
[TBL] [Abstract][Full Text] [Related]
19. The PIG-A mutation and absence of glycosylphosphatidylinositol-linked proteins do not confer resistance to apoptosis in paroxysmal nocturnal hemoglobinuria.
Ware RE; Nishimura J; Moody MA; Smith C; Rosse WF; Howard TA
Blood; 1998 Oct; 92(7):2541-50. PubMed ID: 9746796
[TBL] [Abstract][Full Text] [Related]
20. Paroxysmal nocturnal hemoglobinuria from bench to bedside.
Pu JJ; Brodsky RA
Clin Transl Sci; 2011 Jun; 4(3):219-24. PubMed ID: 21707954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
